Skip to content
Delayed ~15 min

ADAM ADAMAS

Permanent stock page ↗

Real Estate · Russell 2000

Next earnings: not announced yet

What 8 analyst firms say about ADAMAS: their latest ratings, price targets and how far the stock is from them. How it works

5.69 USD−0.23 (−3.89%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+65.2%to the avg target 9.40 USD+3.71 USD
Buy 2 · Hold 5 · Sell 0

7 rated views · 8 analyst/firm records · 8 firms

Latest report30 Oct 2026avg report date 9 Sep
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8052
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8041

Recent analyst activity · last 90 days

Our tracked history has 11 reports on ADAM from 6 analyst firms in the last 90 days (8 firms in the past year).

Comparing each firm's latest target with its previous one: 2 lowered it and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Keefe Bruyette lowered its target from $9.00 (set 20 Feb 2026) to $8.50 on 30 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
B Riley SecuritiesTimothy D'AgostinoHold30 Oct 20269.50 USD · 30 Jul 2026
BTIGEric J HagenHold2 Apr 2026—
JonestradingJason WeaverBuy29 Oct 20269.50 USD
Keefe Bruyette & WoodsBose GeorgeHold30 Oct 20268.50 USD
Maxim GroupMichael K DianaBuy31 Jul 202610.00 USD
UBSMarissa LoboHold19 Aug 20269.50 USD
Weiss RatingsUnnamed analyst—19 Oct 2026—
Data feed RESEARCHResearch TeamHold28 Sep 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:12 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.